Xerostomia Due to Radiotherapy Clinical Trial
Official title:
Phase II Clinical Trial to Evaluate the Effect and Safety of MSV * in Xerostomia * Adult Autologous Bone Marrow Mesenchymal Stem Cells, Expanded Under GMP of IBGM
Phase II not controlled, open-label, prospective, single center clinical trial
- Determine changes in the xerostomia characteristics and discomfort degree by means of
questionnaires addressed to the physician and subject of study.
- Determine the volume of submaxilar saliva without stimulation and with stimulation by
sialometry (SL).
- Detect changes in volume, vascularization and fibrosis of submaxillary glands based on
magnetic resonance imaging (MRI) with contrast.
- Detect changes of submaxillary gland functionalism based on Gammagraphy (GF).
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Not yet recruiting |
NCT03530735 -
Finger-prick Autologous Blood (FAB) for Use in Dry Mouth
|
N/A | |
| Recruiting |
NCT03972072 -
MRI - Guided Adaptive RadioTHerapy for Reducing XerostomiA in Head and Neck Cancer (MARTHA-trial)
|
N/A | |
| Completed |
NCT03418792 -
Functional Sparing of Salivary Glands Using MRI Sialography for Patients Undergoing Definitive Radiation Therapy for Head and Neck Cancers of the Oropharynx
|
N/A | |
| Active, not recruiting |
NCT03874572 -
Allogeneic Mesenchymal Stem Cells for Radiation-induced Hyposalivation and Xerostomia/Dry Mouth
|
Phase 1 | |
| Completed |
NCT04043104 -
A Phase 1 Open-Label, Dose Escalation Study to Determine the Optimal Dose, Safety, and Activity of AAV2hAQP1 in Subjects With Radiation-Induced Parotid Gland Hypofunction and Xerostomia
|
Phase 1 | |
| Enrolling by invitation |
NCT03876197 -
Mesenchymal Stem Cells for Radiation-induced Xerostomia
|
Phase 1/Phase 2 |